RESP022b - OSA Links to CVD and Diabetes Part 2
This second part focuses on the treatment of sleep disordered breathing, and explains how care professionals can improve OSA screening and therapy in their practice.
This is the second of a two-part series of courses about the relationship between Obstructive Sleep Apnea (OSA) and both cardiovascular disease (CVD) and diabetes. This second part focuses on the treatment of sleep disordered breathing, and explains how care professionals can improve OSA screening and therapy in their practice. Learning objectives: 1.Define the most common form of sleep disordered breathing: Obstructive Sleep Apnea (OSA); 2. Review current trends in co-morbid conditions: cardiovascular disease (CVD), including hypertension, arrhythmias and heart failure; and type 2 diabetes; 3. Explain the physiologic association between OSA and CVD, and OSA and type 2 diabetes; 4. Describe the benefits of positive airway pressure (PAP) therapy in treating OSA; 5. Educate and help develop strategies to improve medical management of patients with co-morbid conditions who also suffer from OSA. To successfully complete this course, you must attain a minimum score of 80% on the final exam and complete the course training survey.Continuing education: 1.0 contact hours of Continuing Respiratory Care Education (CRCE) credit by the American Association for Respiratory Care (AARC); VGM Education is authorized by IACET to offer 0.1 CEUs for this program.